|
Press Releases |
|
 |
|
Thursday, April 23, 2009 |
|
Teams of Scientists in Singapore and Hungary Collaborate to Discover Cures and Therapies to Advance Healthcare Delivery |
Singapore's Agency for Science, Technology and Research (A*STAR) and Hungarys National Office for Research and Technology (NKTH) awarded grants to four new research projects in cancer, bio-imaging for stem cell therapy, stroke rehabilitation and drug delivery at the 2nd Singapore-Hungary Joint Symposium held in Singapore today. more info >> |
|
Exploit Technologies Launches International Incubator Initiative (Icube) |
Exploit Technologies launched the International Incubation Initiative, or Icube, at the New Zealand Business Forum on 22 April 2009. Icube seeks to encourage innovation by providing to start-ups of participating incubators greater access to incubators internationally. more info >> |
|
A*STAR, Lombardy Forge Further Links For Science Partnership |
The Agency for Science, Technology and Research (A*STAR) announced today that Mr Lim Chuan Poh, Chairman of A*STAR, signed a Memorandum of Intent (MOI) with Mr Massimo Buscemi, Minister for Public Utilities and Sustainable Development for the region of Lombardy, Italy, to expand scientific collaborative activities between scientists from A*STAR and Lombardy. more info >> |
|
Thursday, April 9, 2009 |
|
A*STAR and SMEs in Strategic Partnership to Create Value and Transform Singapore's Economy |
The Agency for Science, Technology and Research (A*STAR) announced today at the GET-Up Seminar that more than 250 local Small and Medium Enterprises (SMEs), which were on the Growing Enterprises with Technology Upgrade (GET-Up) programme, projected twice as much revenue and employment growth over the next three years as their counterparts which were not on GET-Up. more info >> |
|
Tuesday, December 6, 2022 |
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
Thursday, June 2, 2022 |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR. more info >> |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
more info >> |
|
Thursday, September 30, 2021 |
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health and operated by private healthcare providers. more info >> |
|
Friday, July 31, 2020 |
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving "First Patient First Visit[1]" in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of clinical testing, which for the first time, will look at efficacy in addition to assessing the safety of ETC-159 in treating different types of cancers. more info >> |
|
Friday, July 24, 2020 |
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research (A*STAR). more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Euro Manganese Closes C$11.2 million (A$12.3 million) Financing
May 29, 2025 16:09 HKT/SGT
|
|
|
Honda、2025年4月度 四輪車 生産・販売・輸出実績を発表
May 29, 2025 15:20: JST
|
|
|
三菱造船、防衛省向け海洋観測艦「あかし」の命名・進水式を下関で実施
May 29, 2025 15:00: JST
|
|
|
トヨタ、2025年4月 販売・生産・輸出実績を発表
May 29, 2025 13:34: JST
|
|
|
Honda、「ACCORD」に新グレード「e:HEV Honda SENSING 360+」を設定し発売
May 29, 2025 11:30: JST
|
|
|
エーザイ、米国におけるレンバチニブに関する特許侵害訴訟の勝訴について
May 29, 2025 11:30: JST
|
|
|
Synology參與COMPUTEX 2025 展示全新企業級儲存、備份及影像監控等解決方案
May 29, 2025 11:00 HKT/SGT
|
|
|
SAPPE Makes a Global Splash in the Beverage Market, Unveils Global Campaign "Life's too Short, You Gotta Chew" at THAIFEX - ANUGA ASIA 2025
May 29, 2025 08:00 HKT/SGT
|
|
|
Global Leaders Gather for XIII International Meeting on International Cooperation
May 28, 2025 21:30: JST
|
|
|
Global Leaders Gather for XIII International Meeting on International Cooperation
May 28, 2025 20:30 HKT/SGT
|
|
|
Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully
May 28, 2025 19:57 HKT/SGT
|
|
|
New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China
May 28, 2025 17:45 JST
|
|
|
Modern Dental Group's Thai Subsidiary Hexa Ceram Held 30th Anniversary Celebration and Dental Symposium
May 28, 2025 16:44 HKT/SGT
|
|
|
現代牙科集團泰國公司Hexa Ceram舉辦三十周年慶典暨牙科論壇
May 28, 2025 16:30 HKT/SGT
|
|
|
现代牙科集团泰国公司Hexa Ceram举办三十周年庆典暨牙科论坛
May 28, 2025 16:12 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|